Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis

OBJECTIVE: Both in vitro and in vivo studies indicate that metformin inhibits cancer cell growth and reduces cancer risk. Recent epidemiological studies suggest that metformin therapy may reduce the risks of cancer and overall cancer mortality among patients with type 2 diabetes. However, data on it...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhi-Jiang, Zheng, Zhi-Jie, Kan, Haidong, Song, Yiqing, Cui, Wei, Zhao, Genming, Kip, Kevin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Reviews/Commentaries/ADA Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177711/
https://www.ncbi.nlm.nih.gov/pubmed/21949223
http://dx.doi.org/10.2337/dc11-0512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177711/
https://www.ncbi.nlm.nih.gov/pubmed/21949223
http://dx.doi.org/10.2337/dc11-0512

Ejemplares similares